Frequency: every 6 months

OTHER2 trials

Sponsors

Intas Pharmaceuticals Ltd Biopharma Division, McMaster University

Conditions

Health Condition 1: M808- Other osteoporosis with current pathological fractureLung MetastasesSoft Tissue Sarcoma

Phase 4

A study of Denosumab in postmenopausal women and men with osteoporosis (weak and brittle bones) at high risk of fracture

Active, not recruitingCTRI/2018/10/016049

Intas Pharmaceuticals Ltd Biopharma DivisionHealth Condition 1: M808- Other osteoporosis with current pathological fracture

Target: 200Updated: 2021-11-24

Unknown Phase

Surveillance AFter Extremity Tumor surgerY

Active, not recruitingNCT03944798

McMaster UniversityLung Metastases, Soft Tissue Sarcoma

Start: 2019-11-19End: 2027-12-31Updated: 2024-11-22

Related Papers

The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial

BMJ Open2019-09-0125 citations